Literature DB >> 15625165

A patient-centered health care delivery system by a university obstetrics and gynecology department.

Garland D Anderson1, Carolyn Nelson-Becker, Edward V Hannigan, Abbey B Berenson, Gary D V Hankins.   

Abstract

At the University of Texas Medical Branch at Galveston, we developed an off-site clinic system that offers a wide array of services to low-income women and their infants over a large geographic area. These clinics strove toward cultural sensitivity and competency. This patient-centered approach was well accepted and appreciated by our patients. The clinics offered unique, value-added services including combined location with other needed services, on-site laboratory and antepartum testing, the option for delivery at the University of Texas Medical Branch at Galveston in a Birth Center by certified nurse midwives from the clinics, 2 high-level ultrasound "hub" centers in the outlying region that offer level II ultrasound and maternal-fetal medicine specialist consultation on site, and linkage of all sites to our electronic medical record, telemedicine, and telegenetics consultation. We also developed an off-site domiciliary facility at the University of Texas Medical Branch at Galveston. From 1989 to 2004, our clinics grew from 12 to 38 (now serving 123 Texas counties). Annual patient visits increased from approximately 34,000 to 342,926. Deliveries at the University of Texas Medical Branch at Galveston grew from 3,959 in 1990 to an estimated 6,400 in 2004. Underscoring this increase was the probable loss of at least 1,500 deliveries to local hospitals that had previously denied or discouraged admission to Medicaid-eligible pregnant women. Many women chose to deliver in our hospital even although they had to travel a longer distance to reach our facility. Our experience has shown that patient-centered care can be a viable business strategy to maintain and expand patient volumes and will work even where there are serious geographic disadvantages.

Entities:  

Mesh:

Year:  2005        PMID: 15625165     DOI: 10.1097/01.AOG.0000146288.28195.27

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Is Spanish language a barrier to domestic violence assessment?

Authors:  Aminah Jatoi; Carmen Radecki Breitkopf
Journal:  J Womens Health (Larchmt)       Date:  2011-06-01       Impact factor: 2.681

Review 2.  The role of unconscious bias in surgical safety and outcomes.

Authors:  Heena P Santry; Sherry M Wren
Journal:  Surg Clin North Am       Date:  2011-12-06       Impact factor: 2.741

3.  Predictors of sleep characteristics among women in southeast Texas.

Authors:  Alisa B Kachikis; Carmen Radecki Breitkopf
Journal:  Womens Health Issues       Date:  2011-08-27

4.  The influence of cultural adaptation and sexual risk behaviors on cervical cytology in a Hispanic population.

Authors:  Kristy K Ward; Angelica M Roncancio; Carmen Radecki Breitkopf
Journal:  Am J Obstet Gynecol       Date:  2010-09-22       Impact factor: 8.661

5.  A theory-based approach to understanding follow-up of abnormal Pap tests.

Authors:  Carmen Radecki Breitkopf; Heidi C Pearson
Journal:  J Health Psychol       Date:  2009-04

6.  Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial.

Authors:  Carmen Radecki Breitkopf; Lauren Dawson; James J Grady; Daniel M Breitkopf; Carolyn Nelson-Becker; Russell R Snyder
Journal:  Health Psychol       Date:  2013-06-03       Impact factor: 4.267

7.  Recycling attitudes and behavior among a clinic-based sample of low-income Hispanic women in southeast Texas.

Authors:  Heidi C Pearson; Lauren N Dawson; Carmen Radecki Breitkopf
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Keywords to recruit Spanish- and English-speaking participants: evidence from an online postpartum depression randomized controlled trial.

Authors:  Alinne Z Barrera; Alex R Kelman; Ricardo F Muñoz
Journal:  J Med Internet Res       Date:  2014-01-09       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.